|
1
|
JB PucilowskaKL WilliamsPK
LundFibrogenesis. IV Fibrosis and inflammatory bowel disease:
cellular mediators and animal modelsAm J Physiol Gastrointest Liver
Physiol279G653G659200011005750
|
|
2
|
F RiederC FiocchiIntestinal fibrosis in
inflammatory bowel disease - current knowledge and future
perspectivesJ Crohns
Colitis2279290200810.1016/j.crohns.2008.05.00921172225
|
|
3
|
F RiederC FiocchiIntestinal fibrosis in
inflammatory bowel disease: progress in basic and clinical
scienceCurr Opin
Gastroenterol24462468200810.1097/MOG.0b013e3282ff8b3618622160
|
|
4
|
PA GregoryAG BertEL PatersonThe miR-200
family and miR-205 regulate epithelial to mesenchymal transition by
targeting ZEB1 and SIP1Nat Cell
Biol10593601200810.1038/ncb172218376396
|
|
5
|
S ObaS KumanoE SuzukimiR-200b precursor
can ameliorate renal tubulointerstitial fibrosisPLoS
One5e13614201010.1371/journal.pone.001361421049046
|
|
6
|
S LamouilleR DerynckCell size and invasion
in TGF-beta-induced epithelial to mesenchymal transition is
regulated by activation of the mTOR pathwayJ Cell
Biol178437451200710.1083/jcb.20061114617646396
|
|
7
|
JJ HillTL TremblayC CantinM
O’Connor-McCourtJF KellyAE LenferinkGlycoproteomic analysis of two
mouse mammary cell lines during transforming growth factor
(TGF)-beta induced epithelial to mesenchymal transitionProteome
Sci72200910.1186/1477-5956-7-219128513
|
|
8
|
AB RobertsF TianSD ByfieldSmad3 is key to
TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis,
tumor suppression and metastasisCytokine Growth Factor
Rev171927200610.1016/j.cytogfr.2005.09.00816290023
|
|
9
|
J XuS LamouilleR DerynckTGF-beta-induced
epithelial to mesenchymal transitionCell
Res19156172200910.1038/cr.2009.519153598
|
|
10
|
K GravdalOJ HalvorsenSA HaukaasLA AkslenA
switch from E-cadherin to N-cadherin expression indicates
epithelial to mesenchymal transition and is of strong and
independent importance for the progress of prostate cancerClin
Cancer Res1370037011200710.1158/1078-0432.CCR-07-126318056176
|
|
11
|
S NakajimaR DoiE ToyodaN-cadherin
expression and epithelial-mesenchymal transition in pancreatic
carcinomaClin Cancer
Res1041254133200410.1158/1078-0432.CCR-0578-0315217949
|
|
12
|
JB KimS IslamYJ KimN-Cadherin
extracellular repeat 4 mediates epithelial to mesenchymal
transition and increased motilityJ Cell
Biol15111931206200010.1083/jcb.151.6.119311121435
|
|
13
|
K VuoriluotoH HaugenS KiviluotoVimentin
regulates EMT induction by Slug and oncogenic H-Ras and migration
by governing Axl expression in breast
cancerOncogene3014361448201110.1038/onc.2010.50921057535
|
|
14
|
J IvaskaVimentin: central hub in EMT
induction?Small Gtpases25153201110.4161/sgtp.2.1.1511421686283
|
|
15
|
G CarpinoS MoriniS Ginanni
CorradiniAlpha-SMA expression in hepatic stellate cells and
quantitative analysis of hepatic fibrosis in cirrhosis and in
recurrent chronic hepatitis after liver transplantationDig Liver
Dis37349356200510.1016/j.dld.2004.11.009
|
|
16
|
K InaH KitamuraS TatsukawaY
FujikuraSignificance of alpha-SMA in myofibroblasts emerging in
renal tubulointerstitial fibrosisHistol
Histopathol26855866201121630215
|
|
17
|
N AkpolatS YahsiA GodekmerdanM YalnizK
DemirbagThe value of alpha-SMA in the evaluation of hepatic
fibrosis severity in hepatitis B infection and cirrhosis
development: a histopathological and immunohistochemical
studyHistopathology47276280200510.1111/j.1365-2559.2005.02226.x16115228
|
|
18
|
Y MurakamiH ToyodaM TanakaThe progression
of liver fibrosis is related with overexpression of the miR-199 and
200 familiesPLoS
One6e16081201110.1371/journal.pone.001608121283674
|
|
19
|
W Van MoerkerckeG DeboeverG LambrechtK
HertveldtSevere bridging fibrosis of the colon in a man with
inflammatory bowel diseaseEndoscopy39Suppl 1E294200717957610
|
|
20
|
J AiR ZhangY LiCirculating microRNA-1 as a
potential novel biomarker for acute myocardial infarctionBiochem
Biophys Res Commun3917377201010.1016/j.bbrc.2009.11.00519896465
|
|
21
|
N KosakaH IguchiT OchiyaCirculating
microRNA in body fluid: a new potential biomarker for cancer
diagnosis and prognosisCancer
Sci10120872092201010.1111/j.1349-7006.2010.01650.x20624164
|
|
22
|
AM ZahmM ThayuNJ HandA HornerMB LeonardJR
FriedmanCirculating microRNA is a biomarker of pediatric Crohn
diseaseJ Pediatr Gastroenterol
Nutr532633201110.1097/MPG.0b013e31822200cc21546856
|
|
23
|
GK WangJQ ZhuJT ZhangCirculating microRNA:
a novel potential biomarker for early diagnosis of acute myocardial
infarction in humansEur Heart
J31659666201010.1093/eurheartj/ehq01320159880
|
|
24
|
R MahnLC HeukampS RogenhoferA von
RueckerSC MullerJ EllingerCirculating microRNAs (miRNA) in serum of
patients with prostate
cancerUrology7712651266201110.1016/j.urology.2011.01.02021539977
|
|
25
|
Y D’AlessandraP DevannaF LimanaCirculating
microRNAs are new and sensitive biomarkers of myocardial
infarctionEur Heart J3127652773201020534597
|
|
26
|
SK GuptaC BangT ThumCirculating microRNAs
as biomarkers and potential paracrine mediators of cardiovascular
diseaseCirc Cardiovasc
Genet3484488201010.1161/CIRCGENETICS.110.95836320959591
|
|
27
|
KZ QuK ZhangH LiNH AfdhalM
AlbitarCirculating microRNAs as biomarkers for hepatocellular
carcinomaJ Clin
Gastroenterol45355360201110.1097/MCG.0b013e3181f18ac221278583
|
|
28
|
C RothB RackV MullerW JanniK PantelH
SchwarzenbachCirculating microRNAs as blood-based markers for
patients with primary and metastatic breast cancerBreast Cancer
Res12R90201010.1186/bcr276621047409
|
|
29
|
HM HeneghanN MillerAJ LoweryKJ SweeneyJ
NewellMJ KerinCirculating microRNAs as novel minimally invasive
biomarkers for breast cancerAnn
Surg251499505201010.1097/SLA.0b013e3181cc939f20134314
|
|
30
|
R ContuMV LatronicoG CondorelliCirculating
microRNAs as potential biomarkers of coronary artery disease: a
promise to be fulfilled?Circ
Res107573574201010.1161/CIRCRESAHA.110.22798320814026
|
|
31
|
PS MitchellRK ParkinEM KrohCirculating
microRNAs as stable blood-based markers for cancer detectionProc
Natl Acad Sci
USA1051051310518200810.1073/pnas.080454910518663219
|
|
32
|
W ZhuW QinU AtasoyER SauterCirculating
microRNAs in breast cancer and healthy subjectsBMC Res
Notes289200910.1186/1756-0500-2-8919454029
|
|
33
|
S FichtlschererS De RosaH FoxCirculating
microRNAs in patients with coronary artery diseaseCirc
Res107677684201010.1161/CIRCRESAHA.109.21556620595655
|
|
34
|
M TsujiuraD IchikawaS KomatsuCirculating
microRNAs in plasma of patients with gastric cancersBr J
Cancer10211741179201010.1038/sj.bjc.660560820234369
|
|
35
|
S KomatsuD IchikawaH TakeshitaCirculating
microRNAs in plasma of patients with oesophageal squamous cell
carcinomaBr J Cancer105104111201110.1038/bjc.2011.19821673684
|
|
36
|
Z ZuoGA CalinHM de PaulaCirculating
microRNAs let-7a and miR-16 predict progression-free survival and
overall survival in patients with myelodysplastic
syndromeBlood118413415201110.1182/blood-2011-01-33070421602527
|
|
37
|
J XuC WuX CheCirculating microRNAs,
miR-21, miR-122, and miR-223, in patients with hepatocellular
carcinoma or chronic hepatitisMol
Carcinog50136142201110.1002/mc.2071221229610
|
|
38
|
T SukataK SumidaM KushidaCirculating
microRNAs, possible indicators of progress of rat
hepatocarcinogenesis from early stagesToxicol
Lett2004652201110.1016/j.toxlet.2010.10.01321035526
|
|
39
|
K WangS ZhangB MarzolfCirculating
microRNAs, potential biomarkers for drug-induced liver injuryProc
Natl Acad Sci USA10644024407200910.1073/pnas.081337110619246379
|
|
40
|
JM Lopez-NovoaMA NietoInflammation and
EMT: an alliance towards organ fibrosis and cancer progressionEMBO
Mol Med1303314200910.1002/emmm.20090004320049734
|
|
41
|
PK LundCC ZunigaIntestinal fibrosis in
human and experimental inflammatory bowel diseaseCurr Opin
Gastroenterol17318323200110.1097/00001574-200107000-0000417031177
|
